Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Performance and Safety of DTXO App, an Innovative Digital Therapy, in Improving Weight Loss and Weight-Loss Maintenance of Patients With Obesity by Increasing Their Adherence to Dietary, Exercise Regimens and Psycho-Behavioral Program

NCT05394779 is registered in ClinicalTrials.gov with Advice Pharma Group srl as lead sponsor.

NCT NCT05394779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05394779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Performance and Safety of DTXO App, an Innovative Digital Therapy, in Improving Weight Loss and Weight-Loss Maintenance of Patients With Obesity by Increasing Their Adherence to Dietary, Exercise Regimens and Psycho-Behavioral Program
Lead sponsor
Advice Pharma Group srl
Phase
Not applicable
Overall status
Completed
Start date
August 23, 2022
Completion date
May 30, 2024
Enrollment
246 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

behavioral disorder, body weight, diet habit, diet, healthy, dietary habits, health behavior, life style, nutrition disorders, nutrition, healthy, obesity, overweight and obesity, weight loss